A slimming aid made from a southern African cactus is set to be developed by UK firm Phytopharm and Unilever.Under the deal, production of the Hoodia cactus at Phytopharm's nursery in South Africa will also rise from eight million plants to potentially hundreds of millions, said Phytopharm chief executive Richard Dixey.Phytopharm will receive an initial fee of £6.5m from Unilever - out of a potential total of £21m - as well as future royalties on product sales.The firm had initially hoped to market a slimming drug from Hoodia with Pfizer.Anglo-Dutch food giant Unilever will help the pharmaceutical firm develop the snacks containing Hoodia extract.